A Bitter Pill: How pharmaceuticals are rewriting the rules of rivers, marine life and ecosystems that depend on them
I wrote yesterday about Sinking Cities, and about the damage caused by unsustainable water depletion. The 28 cities with the largest population in the US are all sinking. That creates problems that are very expensive to fix - and are likely to trigger long-term consequencs about viability, about migration, collapsed real estate values and dead cities that are very familiar to a history of urban settlement.
Today’s post is also about damage done by human choices - especially to rivers and to their ecosystems. I’ll write more about pharmaceuticals/medicine/drugs for paid subscribers later this week with reference to Trump’s order on prices. I’ll also be writing about the tariff debacle in the next day or two as well.
Of course, in the early twenty-first century, our understanding of environmental degradation was shaped by deforestation, carbon dioxide, and plastic: these were the visible and quantifiable scars of modernity. But a new pair of scientific studies reveals a different, quieter crisis - one that unfolds not in the sky or the rainforest canopy, but in the water beneath our bridges and the rivers that once formed the arteries of civilizations. The crisis comes not from oil spills or industrial dyes, but from something far more intimate: the pills we swallow.
One is by three scholars at MGill University in Montreal, led by Heloisa Ehalt Macedo and two US colleagues who work in healthcare. The study maps a startling reality: over 8,500 tonnes of antibiotics, all consumed by humans, are discharged into the world's rivers every year. Even after accounting for waste treatment and decay, more than 3,000 tonnes still find their way into oceans or sink into inland water basins. This figure excludes veterinary and industrial sources, meaning the true total is significantly higher.
These antibiotics do not simply disappear. They linger, reshaping microbial life, promoting resistance, and exerting toxicological stress on aquatic organisms. A staggering 6 million kilometres of rivers worldwide now exceed safe thresholds for antibiotic concentrations. This is not a problem confined to the industrial heartlands of Europe or North America. It is global, with particularly acute risk in Southeast Asia, sub-Saharan Africa, and parts of South America.
The implications are multidimensional. Ecological toxicity is only the beginning. Perhaps more alarming is the prospect of antimicrobial resistance (AMR) - a phrase that should ring in our ears with the same alarm as ‘climate crisis’, and one I am working on for a new project about future global risks: if current trends continue, resistant bacterial infections could become the leading cause of global deaths by 2050.
But this story is not just one of distant mortality statistics. It is also a story about how the altered chemistry of our water reshapes the behavior and biology of animals.
That is where the second study provides an extraordinary complement. A team led by Jack Brand and Michael Bertram of researchers from all around the world set out to investigate the effects of psychoactive pharmaceutical residues on the river-to-sea migration of Atlantic salmon in Sweden’s River Dal. Their method was precise: smolts (young salmon in their initial migration phase) were implanted with low doses of clobazam - a benzodiazepine commonly prescribed for anxiety disordes. Their migration was then tracked across dams, reservoirs, and into the Baltic Sea.
The results are both fascinating and unsettling. Fish exposed to clobazam passed through hydropower dams more quickly and were more likely to complete their migration. In ecological terms, the drug made them bolder, faster - and possibly, in the short term, more successful. In human terms, we might say the fish were ‘less anxious’.
But this is no simple feel-good tale of pharmacological uplift. Clobazam also altered shoaling behavior - the tight group formations that provide safety from predators. When faced with threat, exposed salmon were less cohesive, more erratic, more vulnerable. In a lab, this is a behavioural curiosity. In the wild, it could be a matter of life or death.
This raises troubling questions. We do not know what happens to salmon that reach the sea dosed with clobazam behave after their arrival, or how their altered neurochemistry affects their navigation, breeding, or survival. Nor do we know what long-term exposure to antidepressants, opioids, or antibiotic residues does to the base of the food chain - such as algae, plankton and bacteria. What we do know is that these chemicals are now globally present, persistent, and often designed to act at minute concentrations on ancient, conserved neurobiological pathways.
There is a bleak irony here. Pharmaceuticals are among the most regulated products in human society. They are tested, trialed, scrutinized, and tightly controlled when they enter our bodies. Yet once they leave us unmetabolized, flushed into sewers, or leaching from landfill, they become largely invisible and unmonitored. They pass silently into the environment, where they begin to sculpt a world in their image.
The numbers and the consequences are staggering. More than 750 million people now live within 10 kilometres of rivers where antibiotic concentrations exceed safety thresholds. Many of these are in regions with poor or non-existent water treatment infrastructure.
This is not just an ecological issue, but one of environmental justice. The over-prescription of antibiotics in wealthier countries, the rising consumption of antibiotics in the Global South, and the failure to invest in wastewater treatment plants all converge to create a planetary cascade of contamination.
What does it mean to live in a world where rivers now contain traces of our every ill - antibiotics, antidepressants, antipsychotics, anxiolytics? In ancient societies, rivers were sacred. They were the dwelling places of gods, the sources of fertility, the repositories of memory. Today, they are something else entirely: archives of human pathology, mirror-worlds of our internal chemistry.
And yet, these revelations demand more than awe or despair. They demand a rethinking of infrastructure, policy, and morality. Technological solutions exist. Advanced wastewater treatments can strip out pharmaceuticals. Better regulations can control overuse. But all of this will require investment, political will, and—above all—a shift in how we think about the boundaries between ourselves and the environment. The separation is illusory. What we flush away does not vanish. It returns, altered, potent, and often misunderstood.
In The Earth Transformed, I argued that climate change, environmental degradation, and human history are inseparable. These new studies confirm that thesis in molecular detail. The boundaries between our bodies and the biosphere are more porous than we imagined. Our medical systems, our habits of consumption, and our blind faith in modern chemistry are no longer private matters: they ripple outwards into the rivers, into fish brains, into microbial genomes.
Whether we like it or not, we are writing a new chapter in planetary history, one where the waters that once sustained life now carry the residues of its fragmentation.
This is not a call to despair. It is a call to think about societal and ecological consequences. To see clearly is the first step toward acting wisely. The rivers are speaking. The question is whether we are willing to listen.
On that, note, I’d recommend Robert Macfarlane’s beautiful new book Is A River Alive? for a lovely ode to rivers, the life they hold, the importance of their roles in the past and present - and to why their degradation is so damaging.
More soon.